Cushing’s disease is complex, and individualized approaches require the consideration of many patient factors. You and your patient also need to know what to expect in terms of therapeutic response and speed of recovery. Tune in as Drs. Maria Fleseriu and Irina Bancos address these challenges and more!

In this chapterized panel discussion, Drs. Aparna Parikh, Dustin Deming, and Scott Kopetz take us through NCCN recommended guidelines and best practices for identifying biomarkers. Armed with this knowledge, you’ll be able to select systemic therapies more accurately for your patients with MSI-high disease, as well as patients with HER2-amplified CRC.

Take a deep dive into current and ongoing clinical trials related to MET inhibitors and discover the key distinctions between these agents, such as dosing differences. Our experts also have recommendations on appropriate therapy selection for your patients with advanced NSCLC harboring MET exon 14 skipping mutations.

Join us as Dr. Jyoti Patel illustrates her approach to treating a 75-year-old patient who was recently diagnosed with stage IV NSCLC harboring a MET exon 14 skipping mutation—then put these tips to use in your own practice!

This EMCREG-International Satellite Symposium highlights immediate interventions for three types of life-threatening bleeding in patients on an anticoagulant: intracranial hemorrhage, gastrointestinal bleeding and trauma-related bleeding. The faculty for this CME-certified event includes experts who will provide didactic and case study presentations. Plus, the faculty will also participate in an interactive panel discussion with the audience. This enduring activity was originally presented as a satellite symposium which was held during the EUSEM 2022 Congress in Berlin, Germany.

This EMCREG-International Satellite Symposium highlights immediate interventions for three types of life-threatening bleeding in patients on an anticoagulant: intracranial hemorrhage, gastrointestinal bleeding and trauma-related bleeding. The faculty for this CME-certified event includes experts who will provide didactic and case study presentations. Plus, the faculty will also participate in an interactive panel discussion with the audience. This enduring activity was originally presented as a satellite symposium which was held during the EUSEM 2022 Congress in Berlin, Germany.

This activity addresses disparities in the treatment of vasomotor symptoms faced by menopausal women of diverse racial and ethnic backgrounds. Faculty discussion covers overcoming these disparities, guideline recommendations, a novel mechanism for controlling vasomotor symptoms, and strategies to educate patients. First-hand patient testimonials complement the discussion.

Current and Emerging Treatment Approaches
Dr. Kagan and Dr. Kapoor discuss available and emerging hormonal and nonhormonal approaches to managing vasomotor symptoms.

This activity addresses disparities in the treatment of vasomotor symptoms faced by menopausal women of diverse racial and ethnic backgrounds. Faculty discussion covers overcoming these disparities, guideline recommendations, a novel mechanism for controlling vasomotor symptoms, and strategies to educate patients. First-hand patient testimonials complement the discussion.

Overview of Disparities
Dr. Kagan and Dr. Neal-Perry review disparities faced by women across the menopause transition.

This activity addresses disparities in the treatment of vasomotor symptoms faced by menopausal women of diverse racial and ethnic backgrounds. Faculty discussion covers overcoming these disparities, guideline recommendations, a novel mechanism for controlling vasomotor symptoms, and strategies to educate patients. First-hand patient testimonials complement the discussion.

Addressing Patient Needs
The faculty panel discusses the selection of therapy to meet unmet clinical needs across diverse women facing the menopause transition.

This EMCREG-International Satellite Symposium highlights immediate interventions for three types of life-threatening bleeding in patients on an anticoagulant: intracranial hemorrhage, gastrointestinal bleeding and trauma-related bleeding. The faculty for this CME-certified event includes experts who will provide didactic and case study presentations. Plus, the faculty will also participate in an interactive panel discussion with the audience. This enduring activity was originally presented as a satellite symposium which was held during the EUSEM 2022 Congress in Berlin, Germany.